Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. The encoded enzyme is regulated by steroid hormones. In tissue culture, the enzyme has been found to generate amyloidogenic fragments from the amyloid precursor protein, suggesting a potential for involvement in Alzheimer's disease. Multiple alternatively spliced transcript variants that encode different isoforms have been identified for this gene.[8]
Yousef GM, Kishi T, Diamandis EP (Mar 2003). "Role of kallikrein enzymes in the central nervous system". Clinica Chimica Acta; International Journal of Clinical Chemistry. 329 (1–2): 1–8. doi:10.1016/S0009-8981(03)00004-4. PMID12589961.
Menendez-Gonzalez M, Castro-Santos P, Suarez A, Calatayud MT, Perez-Pinera P, Martinez M, Ribacoba R, Gutierrez C (May 2008). "Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease". Journal of Alzheimer's Disease. 14 (1): 59–67. doi:10.3233/JAD-2008-14106. PMID18525128.
Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP (Dec 1999). "Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease". Genomics. 62 (2): 251–9. doi:10.1006/geno.1999.6012. PMID10610719.
Gan L, Lee I, Smith R, Argonza-Barrett R, Lei H, McCuaig J, Moss P, Paeper B, Wang K (Oct 2000). "Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region". Gene. 257 (1): 119–30. doi:10.1016/S0378-1119(00)00382-6. PMID11054574.
Zarghooni M, Soosaipillai A, Grass L, Scorilas A, Mirazimi N, Diamandis EP (May 2002). "Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients". Clinical Biochemistry. 35 (3): 225–31. doi:10.1016/S0009-9120(02)00292-8. PMID12074831.
Mitsui S, Okui A, Uemura H, Mizuno T, Yamada T, Yamamura Y, Yamaguchi N (Nov 2002). "Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease". Annals of the New York Academy of Sciences. 977: 216–23. doi:10.1111/j.1749-6632.2002.tb04818.x. PMID12480753.
Magklara A, Mellati AA, Wasney GA, Little SP, Sotiropoulou G, Becker GW, Diamandis EP (Aug 2003). "Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors". Biochemical and Biophysical Research Communications. 307 (4): 948–55. doi:10.1016/S0006-291X(03)01271-3. PMID12878203.
Sauter ER, Lininger J, Magklara A, Hewett JE, Diamandis EP (Feb 2004). "Association of kallikrein expression in nipple aspirate fluid with breast cancer risk". International Journal of Cancer. 108 (4): 588–91. doi:10.1002/ijc.11607. PMID14696124.
Pampalakis G, Kurlender L, Diamandis EP, Sotiropoulou G (Jul 2004). "Cloning and characterization of novel isoforms of the human kallikrein 6 gene". Biochemical and Biophysical Research Communications. 320 (1): 54–61. doi:10.1016/j.bbrc.2004.04.205. PMID15207701.
External links
The MEROPS online database for peptidases and their inhibitors: S01.236